IRadimed Corporation IRMD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 16.66% | -9.63% | 24.13% | 25.17% | 10.45% |
| Total Depreciation and Amortization | 7.57% | 97.12% | 134.54% | 95.03% | 93.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.60% | -26.54% | -33.33% | 606.28% | 8.03% |
| Change in Net Operating Assets | -400.90% | -139.45% | 194.84% | -1,952.46% | -92.86% |
| Cash from Operations | 0.16% | -23.33% | 93.15% | -1.07% | -23.36% |
| Capital Expenditure | 88.58% | 92.98% | 89.10% | 89.46% | 70.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.92% | -37.23% | 70.00% | 54.20% | 37.47% |
| Cash from Investing | 83.23% | 84.31% | 88.03% | 86.38% | 68.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 36.67% | -143.75% | 56.90% | -327.66% | -68.54% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -18.26% | -18.32% | -18.22% | -350.01% | -13.81% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -17.51% | -23.66% | -14.40% | -349.78% | -14.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.21% | 1.54% | 374.04% | -1,146.03% | 10.80% |